Megalevure
Natural health product licensed in Canada
- Other names
- Megalevadura
- Licence holder
- Lallemand Health Solutions (Institut Rosell)
- NPN or DIN-HM
- 80079191
- Status
- Active licence
- Licence date
- 26 July 2017
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium animalis subsp. lactis Source : R-0421 | 5 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| Lactobacillus helveticus Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| Saccharomyces boulardii | 12 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Extrait de Levure, Saccharose, Saveur de banane, Acide ascorbique, Fructooligosaccharides, Maltodextrine, Xylitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sous-population S/O | minimum: 6 years | minimum: 1 packet ; maximum: 2 packet | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Enfants | minimum: 1 year ; maximum: 6 years | 1 packet | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Source of probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occurs and/or persists beyond 3 days, discontinue use and consult a health care practitioner. This product has come into contact with milk and soy. If you have milk or soy allergy do not use this product.
Source
Official Health Canada record, licence 80079191
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.